Experiment 963685
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | HOLMES,FA: WALTERS,RS: THERIAULT,RL: FORMAN,AD: NEWTON,LK: RABER,MN: BUZDAR,AU: FRYE,DK: HORTOBAGYI,GN:. (1991). PHASE II TRIAL OF TAXOL, AN ACTIVE DRUG IN THE TREATMENT OF METASTATIC BREAST CANCER.. 83(24) |
| Amount utilized | |
| Compound isolated | |
| Disease | 25 PATIENTS WITH METASTATIC BREAST CANCER WERE USED IN THIS PHASE 2 STUDY. PATIENTS RECEIVED TAXOL EVERY 21 DAYS FOR A MEDIAN OF 11 COURSES. 3 PATIENTS HAD A COMPLETE RESPONSE, 11 SHOWED PARTIAL RESPONSE AND DISEASE PROGRESSED IN ONLY 2 PATIENTS. THE DOSE LIMITING TOXICITY WAS GRANULOCYTOPENIA. |
| Dose amount | 250.0 MG |
| Number | 1 |
| Qualitative result | . |
| Animal | HUMAN ADULT |
| Per unit | SQ M |
| Dose expression | DOSE |